» Articles » PMID: 20363750

Acetylation of Lysine 564 Adjacent to the C-terminal Binding Protein-binding Motif in EVI1 is Crucial for Transcriptional Activation of GATA2

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2010 Apr 6
PMID 20363750
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Ecotropic viral integration site 1 (EVI1) is an important transcription factor for leukemogenesis. EVI1 is a member of a group of transcription factors with C-terminal binding protein (CtBP)-binding motifs that act as transcriptional co-repressors; however, we recently found that EVI1 directly activates GATA2 transcription, which is an important gene for the maintenance of hematopoietic stem cells. We show here that EVI1-activated GATA2 transcripts derive from exon 1S of GATA2, which is specifically activated in neural and hematopoietic cells. EVI1 was acetylated by the histone acetyltransferase p300/CBP association factor (P/CAF) in myeloid leukemia cells and hematopoietic progenitor cells. Acetylation at Lys(564), which is adjacent to the CtBP-binding consensus sequence of EVI1, was found to be important for transcriptional activation of GATA2. Mutation of Lys(564) to alanine (K564A) markedly reduced the ability of EVI1 to bind DNA and activate transcription of GATA2. Furthermore, we confirmed that Lys(564) in EVI1 was specifically acetylated in leukemia and primary hematopoietic cells by using an antibody directed against an acetylated Lys(564) EVI1 peptide. Moreover, co-transfection of P/CAF with EVI1 overcame the suppressive effect of the CtBP co-repressor and resulted in GATA2 transcriptional activation; nonetheless, CtBP2 was still included in the protein complex with EVI1 and P/CAF on the EVI1-binding site in the GATA2 promoter region. Thus, acetylation of EVI1 at Lys(564) by P/CAF enhances the DNA binding capacity of EVI1 and thereby contributes to the activation of GATA2.

Citing Articles

EVI1 dysregulation: impact on biology and therapy of myeloid malignancies.

Birdwell C, Fiskus W, Kadia T, DiNardo C, Mill C, Bhalla K Blood Cancer J. 2021; 11(3):64.

PMID: 33753715 PMC: 7985498. DOI: 10.1038/s41408-021-00457-9.


Interplay between cofactors and transcription factors in hematopoiesis and hematological malignancies.

Wang Z, Wang P, Li Y, Peng H, Zhu Y, Mohandas N Signal Transduct Target Ther. 2021; 6(1):24.

PMID: 33468999 PMC: 7815747. DOI: 10.1038/s41392-020-00422-1.


Emerging Roles of PRDM Factors in Stem Cells and Neuronal System: Cofactor Dependent Regulation of PRDM3/16 and FOG1/2 (Novel PRDM Factors).

Leszczynski P, Smiech M, Parvanov E, Watanabe C, Mizutani K, Taniguchi H Cells. 2020; 9(12).

PMID: 33291744 PMC: 7761934. DOI: 10.3390/cells9122603.


SUMOylation of sPRDM16 promotes the progression of acute myeloid leukemia.

Dong S, Chen J BMC Cancer. 2015; 15:893.

PMID: 26559765 PMC: 4641379. DOI: 10.1186/s12885-015-1844-2.


A remote GATA2 hematopoietic enhancer drives leukemogenesis in inv(3)(q21;q26) by activating EVI1 expression.

Yamazaki H, Suzuki M, Otsuki A, Shimizu R, Bresnick E, Engel J Cancer Cell. 2014; 25(4):415-27.

PMID: 24703906 PMC: 4012341. DOI: 10.1016/j.ccr.2014.02.008.


References
1.
Asou H, Suzukawa K, Kita K, Nakase K, Ueda H, Morishita K . Establishment of an undifferentiated leukemia cell line (Kasumi-3) with t(3;7)(q27;q22) and activation of the EVI1 gene. Jpn J Cancer Res. 1996; 87(3):269-74. PMC: 5921094. DOI: 10.1111/j.1349-7006.1996.tb00216.x. View

2.
Hung H, Lau J, Kim A, Weiss M, Blobel G . CREB-Binding protein acetylates hematopoietic transcription factor GATA-1 at functionally important sites. Mol Cell Biol. 1999; 19(5):3496-505. PMC: 84142. DOI: 10.1128/MCB.19.5.3496. View

3.
Minegishi N, Ohta J, Suwabe N, Nakauchi H, Ishihara H, Hayashi N . Alternative promoters regulate transcription of the mouse GATA-2 gene. J Biol Chem. 1998; 273(6):3625-34. DOI: 10.1074/jbc.273.6.3625. View

4.
Zhang W, Bieker J . Acetylation and modulation of erythroid Krüppel-like factor (EKLF) activity by interaction with histone acetyltransferases. Proc Natl Acad Sci U S A. 1998; 95(17):9855-60. PMC: 21426. DOI: 10.1073/pnas.95.17.9855. View

5.
Morishita K, Parganas E, William C, Whittaker M, Drabkin H, Oval J . Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26. Proc Natl Acad Sci U S A. 1992; 89(9):3937-41. PMC: 525606. DOI: 10.1073/pnas.89.9.3937. View